このエピソードについて

英語
アメリカ合衆国

文字起こし 🔗

過去のエピソードを検索

The Harry Glorikian Showの以前のエピソードを検索します。

このポッドキャストの他のエピソード

Investors and companies in the life science industry have been betting a lot of money over the last few years on a single idea: that computation will help us get a lot better at developing new drugs. But the word “computation” covers a pretty broad range of techniques. And the reason that there are…
If you learned that radiologists looking at CT scans for the traditional signs of coronary artery disease catch only 20 percent of the people who actually have a high risk of a heart attack, and if you learned that there’s a new AI-based test that can catch subtle signs of inflammation in the other…
If you look back at all the health-tech and drug development companies Harry has hosted on the show, an interesting pattern starts to emerge: a very large number of those companies have gone on to enormous growth and success in their markets. It could be that being on the podcast is like a catapult…
One of the most amazing successes in the battle against cancer over the last two decades has been the introduction of antibody drugs that harness the body’s own immune system to kill tumor cells. Finding those drugs may sound like a biology problem rather than a machine learning or a big-data probl…
免責: このページに埋め込まれているポッドキャストとアートワークは Harry Glorikian からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。